Verigraft Is A Swedish Biotechnology Company That Specializes In Developing Personalized Tissue Engineered Grafts For Transplantationthe Company Focuses On Creating Grafts That Closely Resemble The Patient S Own Tissueswhich Helps Reduce The Risk Of Rejection By The Immune Systemthis Innovative Approach Aims To Eliminate The Need For Lifelong Immunosuppression Typically Required In Traditional Organ And Tissue Transplants The Company S Technology Combines Decellularization And Reconditioning Processes To Transform Donated Allogenic Tissues Into Personalized Autologous Like Tissuesverigraft Is Developing Several Productsincluding Its Lead Productp Tevwhich Is In Clinical Development For Treating Severe Chronic Venous Insufficiencyadditionallythe P Tea Grafts Are Designed For Various Vascular Applicationssuch As Coronary Artery Bypass Grafting And Hemodialysis Accesswith The Goal Of Integrating Fully Into The Patient S Body And Reducing Complications With A Small Team Of Around 16 Employeesverigraft Is Based In Sweden And Is Recognized As A Leader In Its Fieldtargeting A Growing Market In The Vascular Graft Sector
No conferences found for this company.
| Company Name | Verigraft Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
